Question
Case 1: Cipla Cipla is one of the biggest manufacturers of bulk drugs and formulations. The company has introduced several formulations and active pharmaceutical ingredients
Case 1: Cipla
Cipla is one of the biggest manufacturers of bulk drugs and formulations. The company has introduced several formulations and active pharmaceutical ingredients (APls). It commissioned the second phase of its manufacturing operations in Goa and has entered into a research alliance for biopharmaceutical products with a Bangalore-based biotech company.
Cipla exports a wide range of APls and formulations to over 150 countries. Cipla has entered into new
arrangements with leading US generic companies for the supply of a wide range of finished dosage formulations. They have obtained approvals from USFDA, MHRA of UK, PIC of Germany and WHO,for most of
their drugs. Its overall profitability was due to the optimisation of resources and implementation of rigorous cost
control measures.
Cipla focuses on technological excellence and innovation to improve its performance both in domestic and international markets. The company has already accepted the growing importance of strategic alliances for research, manufacture and marketing, in the changing business environment.
Question
Discuss the rationale for Cipla's focus on exports and strategic alliances?
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started